Skip to main content
Fig. 8 | Genes and Environment

Fig. 8

From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancer

Fig. 8

NCAPD2 was correlated with immunotherapy in LUAD and LUSC. (A) IHC staining of NCAPD2 in LUAD and LUSC tissues. (B) The expression of NCAPD2 in LUAD and LUSC. (C) NCAPD2 diagnostic value in LUAD and LUSC patients. (D) Associations between NCAPD2 expression and immune subtypes in LUAD and LUSC. (E) Associations between NCAPD2 expression and TME in LUAD and LUSC. (F) The distributions of TIICs at NCAPD2 SCNA category in LUAD and LUSC

Back to article page

Genes and Environment

ISSN: 1880-7062

Contact us